Fil LTD Opti Nose, Inc. Transaction History

Fil LTD

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 09, 2018	SELL	$12.43 - $29.76 $3.34 Million - $8 Million	-268,884 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$18.75 - $28.46 $5.04 Million - $7.65 Million	268,884 New	268,884 $7.52 Million

5.29M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $762M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.